$IGMS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IGM Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IGM Biosciences, Inc.. Get notifications about new insider transactions in IGM Biosciences, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| May 28 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 70.00 | 444 | 31,080 | 116,518 | 117 K to 116.5 K (-0.38 %) |
| May 18 2021 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Grant | A | 45.90 | 45 | 2,066 | 5,587 | 5.5 K to 5.6 K (+0.81 %) |
| May 18 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Grant | A | 45.90 | 288 | 13,219 | 3,057 | 2.8 K to 3.1 K (+10.40 %) |
| May 18 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 900 | 1,251 | 342,140 | |
| May 18 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 68.76 | 456 | 31,355 | 116,962 | 117.4 K to 117 K (-0.39 %) |
| May 18 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 900 | 1,251 | 117,418 | 116.5 K to 117.4 K (+0.77 %) |
| May 06 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 62.32 | 469 | 29,226 | 116,518 | 117 K to 116.5 K (-0.40 %) |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 15,264 | |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 62.50 | 1,243 | 77,688 | 2,769 | 4 K to 2.8 K (-30.98 %) |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 68.03 | 1,257 | 85,514 | 4,012 | 5.3 K to 4 K (-23.86 %) |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 343,040 | |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 68.03 | 481 | 32,722 | 116,987 | 117.5 K to 117 K (-0.41 %) |
| May 05 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 17,764 | |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 17,764 | |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 82.00 | 1,254 | 102,828 | 2,769 | 4 K to 2.8 K (-31.17 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 82.00 | 1,254 | 102,828 | 2,769 | 4 K to 2.8 K (-31.17 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 83.40 | 1,246 | 103,916 | 4,023 | 5.3 K to 4 K (-23.65 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 83.40 | 1,246 | 103,916 | 4,023 | 5.3 K to 4 K (-23.65 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 343,990 | |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 343,990 | |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 82.00 | 1,222 | 100,204 | 116,518 | 117.7 K to 116.5 K (-1.04 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 82.00 | 1,222 | 100,204 | 116,518 | 117.7 K to 116.5 K (-1.04 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 83.40 | 678 | 56,545 | 117,740 | 118.4 K to 117.7 K (-0.57 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 83.40 | 678 | 56,545 | 117,740 | 118.4 K to 117.7 K (-0.57 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,418 | 116.5 K to 118.4 K (+1.63 %) |
| Apr 07 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,418 | 116.5 K to 118.4 K (+1.63 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 300 | 0 | 300 | 0 to 300 |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 2,140 | 1.6 K to 2.1 K (+33.33 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 0 | 535 to 0 (-100.00 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | Topsoe Jakob Haldor | Director | Grant | A | 0.00 | 130 | 0 | 55,257 | 55.1 K to 55.3 K (+0.24 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | Topsoe Christina Teng | Director | Grant | A | 0.00 | 195 | 0 | 35,998 | 35.8 K to 36 K (+0.54 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 211 | 0 | 94,139 | 93.9 K to 94.1 K (+0.22 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 130 | 0 | 3,426,297 | 3.4 M to 3.4 M (0.00 %) |
| Apr 02 2021 | IGMS | IGM Biosciences, I ... | Lee Michael Stewart | Director | Grant | A | 0.00 | 130 | 0 | 842 | 712 to 842 (+18.26 %) |
| Mar 09 2021 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Option Exercise | M | 1.39 | 2,750 | 3,823 | 120,097 | |
| Mar 09 2021 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Buy | M | 1.39 | 2,750 | 3,823 | 5,542 | 2.8 K to 5.5 K (+98.50 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 20,264 | |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 20,264 | |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 90.25 | 1,619 | 146,115 | 2,769 | 4.4 K to 2.8 K (-36.90 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 90.25 | 1,619 | 146,115 | 2,769 | 4.4 K to 2.8 K (-36.90 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 92.44 | 881 | 81,440 | 4,388 | 5.3 K to 4.4 K (-16.72 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 92.44 | 881 | 81,440 | 4,388 | 5.3 K to 4.4 K (-16.72 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 345,890 | |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 345,890 | |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 90.25 | 1,224 | 110,466 | 116,518 | 117.7 K to 116.5 K (-1.04 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 90.25 | 1,224 | 110,466 | 116,518 | 117.7 K to 116.5 K (-1.04 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 92.44 | 676 | 62,489 | 117,742 | 118.4 K to 117.7 K (-0.57 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 92.44 | 676 | 62,489 | 117,742 | 118.4 K to 117.7 K (-0.57 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,418 | 116.5 K to 118.4 K (+1.63 %) |
| Mar 03 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,418 | 116.5 K to 118.4 K (+1.63 %) |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Topsoe Christina Teng | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Option Exercise | A | 91.50 | 40,000 | 3,660,000 | 40,000 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Strohl William | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Schwarzer Fred | CEO and President | Option Exercise | A | 91.50 | 125,000 | 11,437,500 | 125,000 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | A | 91.50 | 50,000 | 4,575,000 | 50,000 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | A | 91.50 | 40,000 | 3,660,000 | 40,000 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Topsoe Jakob Haldor | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 22,764 | |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 96.00 | 1,619 | 155,424 | 2,769 | 4.4 K to 2.8 K (-36.90 %) |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 96.40 | 881 | 84,928 | 4,388 | 5.3 K to 4.4 K (-16.72 %) |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 347,790 | |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 96.00 | 1,226 | 117,696 | 116,473 | 117.7 K to 116.5 K (-1.04 %) |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 96.40 | 674 | 64,974 | 117,699 | 118.4 K to 117.7 K (-0.57 %) |
| Feb 04 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,373 | 116.5 K to 118.4 K (+1.63 %) |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 40.27 | 5,833 | 234,895 | 2,527 | |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 40.27 | 5,833 | 234,895 | 2,527 | |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 16.00 | 5,377 | 86,032 | 6,723 | |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 16.00 | 5,377 | 86,032 | 6,723 | |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 40.27 | 5,833 | 234,895 | 2,895,306 | 2.9 M to 2.9 M (+0.20 %) |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 40.27 | 5,833 | 234,895 | 272,898 | 267.1 K to 272.9 K (+2.18 %) |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 16.00 | 5,377 | 86,032 | 2,889,473 | 2.9 M to 2.9 M (+0.19 %) |
| Jan 29 2021 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 16.00 | 5,377 | 86,032 | 267,065 | 261.7 K to 267.1 K (+2.05 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 25,264 | |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 79.33 | 1,503 | 119,233 | 2,769 | 4.3 K to 2.8 K (-35.18 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 77.27 | 997 | 77,038 | 4,272 | 5.3 K to 4.3 K (-18.92 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 88.07 | 883 | 77,766 | 1,013 | 1.9 K to 1 K (-46.57 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 349,690 | |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 79.25 | 1,102 | 87,334 | 116,473 | 117.6 K to 116.5 K (-0.94 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 77.27 | 798 | 61,661 | 117,575 | 118.4 K to 117.6 K (-0.67 %) |
| Jan 06 2021 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,373 | 116.5 K to 118.4 K (+1.63 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | Topsoe Jakob Haldor | Director | Grant | A | 0.00 | 178 | 0 | 55,127 | 54.9 K to 55.1 K (+0.32 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | Topsoe Christina Teng | Director | Grant | A | 0.00 | 357 | 0 | 35,803 | 35.4 K to 35.8 K (+1.01 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Grant | A | 0.00 | 535 | 0 | 535 | 0 to 535 |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 1,605 | 1.1 K to 1.6 K (+50.00 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | LOBERG MICHAEL D | Director | Gift | G | 0.00 | 535 | 0 | 0 | 535 to 0 (-100.00 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Grant | A | 0.00 | 357 | 0 | 93,928 | 93.6 K to 93.9 K (+0.38 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 178 | 0 | 3,426,167 | 3.4 M to 3.4 M (+0.01 %) |
| Jan 05 2021 | IGMS | IGM Biosciences, I ... | Lee Michael Stewart | Director | Grant | A | 0.00 | 178 | 0 | 712 | 534 to 712 (+33.33 %) |
| Dec 22 2020 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Option Exercise | M | 1.39 | 2,750 | 3,823 | 122,847 | |
| Dec 22 2020 | IGMS | IGM Biosciences, I ... | Tahir Misbah | Chief Financial Off ... | Buy | M | 1.39 | 2,750 | 3,823 | 2,792 | 42 to 2.8 K (+6,547.62 %) |
| Dec 18 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Option Exercise | M | 0.93 | 2,500 | 2,325 | 27,764 | |
| Dec 18 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 86.10 | 1,618 | 139,310 | 2,769 | 4.4 K to 2.8 K (-36.88 %) |
| Dec 18 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Payment of Exercise | F | 89.38 | 882 | 78,833 | 4,387 | 5.3 K to 4.4 K (-16.74 %) |
| Dec 18 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Buy | M | 0.93 | 2,500 | 2,325 | 5,269 | 2.8 K to 5.3 K (+90.29 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | Topsoe Jakob Haldor | Director | Buy | P | 90.00 | 111,111 | 9,999,990 | 10,400,564 | 10.3 M to 10.4 M (+1.08 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | Topsoe Christina Teng | Director | Buy | P | 90.00 | 111,111 | 9,999,990 | 10,400,564 | 10.3 M to 10.4 M (+1.08 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | Haldor Topsoe Holding A/S | 10% Owner | Buy | P | 90.00 | 111,111 | 9,999,990 | 10,400,564 | 10.3 M to 10.4 M (+1.08 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 90.00 | 11,111 | 999,990 | 21,111 | 10 K to 21.1 K (+111.11 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 90.00 | 11,111 | 999,990 | 21,111 | 10 K to 21.1 K (+111.11 %) |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 90.00 | 22,222 | 1,999,980 | 22,222 | 0 to 22.2 K |
| Dec 15 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | P | 0.01 | 667,666 | 6,677 | 667,666 | |
| Dec 11 2020 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.01 | 616,846 | 6,168 | 616,846 | |
| Dec 11 2020 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.01 | 49,820 | 498 | 49,820 | |
| Dec 09 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 1,900 | 2,641 | 351,590 | |
| Dec 09 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 91.00 | 1,219 | 110,929 | 116,473 | 117.7 K to 116.5 K (-1.04 %) |
| Dec 09 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 72.92 | 681 | 49,659 | 117,692 | 118.4 K to 117.7 K (-0.58 %) |
| Dec 09 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 1,900 | 2,641 | 118,373 | 116.5 K to 118.4 K (+1.63 %) |
| Dec 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 353,490 | |
| Dec 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 63.15 | 608 | 38,398 | 116,473 | 117.1 K to 116.5 K (-0.52 %) |
| Dec 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 64.22 | 342 | 21,963 | 117,081 | 117.4 K to 117.1 K (-0.29 %) |
| Dec 03 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,423 | 116.5 K to 117.4 K (+0.82 %) |
| Nov 04 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 354,440 | |
| Nov 04 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 50.00 | 605 | 30,250 | 116,473 | 117.1 K to 116.5 K (-0.52 %) |
| Nov 04 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 52.39 | 345 | 18,075 | 117,123 | 117.5 K to 117.1 K (-0.29 %) |
| Nov 04 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 223 | 0 | 2,883,873 | 2.9 M to 2.9 M (+0.01 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 223 | 0 | 261,465 | 261.2 K to 261.5 K (+0.09 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | Keyt Bruce | Chief Scientific Of ... | Sell | S | 73.59 | 1,000 | 73,590 | 1,896 | 2.9 K to 1.9 K (-34.53 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 2,850 | 3,962 | 355,390 | |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 73.50 | 1,830 | 134,505 | 116,518 | 118.3 K to 116.5 K (-1.55 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 76.13 | 1,020 | 77,653 | 118,348 | 119.4 K to 118.3 K (-0.85 %) |
| Oct 05 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 2,850 | 3,962 | 119,368 | 116.5 K to 119.4 K (+2.45 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 358,240 | |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 77.91 | 609 | 47,447 | 116,518 | 117.1 K to 116.5 K (-0.52 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 71.14 | 341 | 24,259 | 117,127 | 117.5 K to 117.1 K (-0.29 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Option Exercise | M | 1.39 | 950 | 1,321 | 358,240 | |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Sell | S | 77.91 | 609 | 47,447 | 116,518 | 117.1 K to 116.5 K (-0.52 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Payment of Exercise | F | 71.14 | 341 | 24,259 | 117,127 | 117.5 K to 117.1 K (-0.29 %) |
| Sep 18 2020 | IGMS | IGM Biosciences, I ... | Chen Daniel ShinYu | Chief Medical Offic ... | Buy | M | 1.39 | 950 | 1,321 | 117,468 | 116.5 K to 117.5 K (+0.82 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 64.80 | 1,570 | 101,729 | 93,214 | 91.6 K to 93.2 K (+1.71 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 63.58 | 3,351 | 213,044 | 91,644 | 88.3 K to 91.6 K (+3.80 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 63.06 | 2,791 | 176,004 | 88,293 | 85.5 K to 88.3 K (+3.26 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 61.80 | 4,336 | 267,984 | 85,502 | 81.2 K to 85.5 K (+5.34 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 60.86 | 5,033 | 306,333 | 81,166 | 76.1 K to 81.2 K (+6.61 %) |
| Sep 14 2020 | IGMS | IGM Biosciences, I ... | BEHRENS M KATHLEEN | Director | Buy | P | 59.65 | 4,442 | 264,948 | 76,133 | 71.7 K to 76.1 K (+6.20 %) |